Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Tetra Immunogenicity and Safety in Adults and Elderly
NCT02369341Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2015
- Primary completion
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Fluarix Quadrivalent in influenza, sponsored by GSK. Started Apr 2015; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02369341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369341.